Skip to main content
. 2023 May 10;2023(5):CD014682. doi: 10.1002/14651858.CD014682.pub2

Riesner 2008.

Methods Double‐blind, placebo‐controlled, parallel, 2‐arm RCT
8 weeks
Participants People with knee and hip OA
Interventions Fluvoxamine 50‐150 mg
Placebo
Outcomes Pain
WOMAC total score
PGIC
AEs
Notes Unable to ascertain pain duration, unsure if chronic